» Articles » PMID: 34598853

Serum IgG4 Level Predicts COVID-19 Related Mortality

Overview
Specialty General Medicine
Date 2021 Oct 2
PMID 34598853
Citations 18
Authors
Affiliations
Soon will be listed here.
Citing Articles

Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adults.

Diemert D, Zumer M, Bova M, Gibbs-Tewary C, Malkin E, Campbell D PLoS Negl Trop Dis. 2025; 18(12):e0012788.

PMID: 39775205 PMC: 11717351. DOI: 10.1371/journal.pntd.0012788.


An unexpected IgE anti-receptor binding domain response following natural infection and different types of SARS-CoV-2 vaccines.

Portilho A, Silva V, Hermes Monteiro da Costa H, Yamashiro R, de Oliveira I, de Campos I Sci Rep. 2024; 14(1):20003.

PMID: 39198569 PMC: 11358332. DOI: 10.1038/s41598-024-71047-5.


Can human IgG subclasses distinguish between confirmed and unconfirmed SARS-CoV-2 infections?.

Mohamed Bahgat M, Hassan Nasraa M, Nadeem R, Amer K, Hassan W, Abd El-Raouf A J Genet Eng Biotechnol. 2024; 22(3):100399.

PMID: 39179319 PMC: 11345650. DOI: 10.1016/j.jgeb.2024.100399.


Systematic analysis for clinical characteristics and outcomes of IgG4-related disease patients during the COVID-19 pandemic.

Zhang T, Liu H, Tian M, Zhou M, Zhou H, Zhang X Clin Rheumatol. 2024; 43(8):2595-2606.

PMID: 38907850 DOI: 10.1007/s10067-024-07033-z.


A case of IgG4-related ophthalmic disease after SARS-CoV-2 vaccination: case report and literature review.

Zhang P, Wu Q, Xu X, Chen M Front Immunol. 2024; 15:1303589.

PMID: 38455056 PMC: 10917890. DOI: 10.3389/fimmu.2024.1303589.